Annual report
6197.TEDINET S100TUL6
Period2023-04-01 → 2024-03-31
Filed2024-06-27
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 157
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥135.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥131.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥117.2bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥106.2bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥95.7bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥5.5bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥6.3bn | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥5.6bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥6.7bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥6.3bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.1bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥5.4bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥4.1bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥5.4bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.3bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.2bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.5bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.5bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥4.7bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥2.3bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥3.2bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥75.2bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥69.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥70.7bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥60.1bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥57.7bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥54.7bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥48.3bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥20.5bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥21.6bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥20.1bn | at 2022-03-31d | Cons. | Net assets |
| Net assets / equity | ¥18.5bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥16.8bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥15.1bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥12.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥15.1bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.9bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.2bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.0bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥11.8bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥7.9bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥9.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥5.5bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥6.7bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥4.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥2.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥7.4bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.8bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.5bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥1.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥5.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥3.2bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥5.7bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.8bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥24.11 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.53 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.08 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.51 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥50.33 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥24.11 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥33.53 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥37.02 | 2021-04-01 → 2022-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥37.41 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥50.12 | 2019-04-01 → 2020-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥222.07 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥227.83 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥212.96 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥195.51 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥177.7 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 27.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.9% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.5% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.7% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 29.0% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 10.7% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 15.2% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 18.1% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 20.1% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 30.9% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 33,884 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 31,982 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 30,928 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 29,838 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 27,174 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥105.5bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥106.1bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥91.7bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥82.3bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥77.6bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥3.5bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | ¥4.6bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | ¥3.6bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥4.8bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥4.8bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.7bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.4bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥499m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥4.6bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | −¥1.3bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥3.3bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥2.9bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥2.9bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥4.3bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥68.3bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥67.9bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥61.6bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥52.0bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥50.0bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥53.2bn | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥48.2bn | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥15.1bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥19.7bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥18.3bn | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥17.2bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥16.1bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥11.9bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥8.8bn | at 2023-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-14.11 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥34.92 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.25 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.69 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥45.65 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥34.91 | 2022-04-01 → 2023-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥30.2 | 2021-04-01 → 2022-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥30.62 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥45.47 | 2019-04-01 → 2020-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥20 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥19.5 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥19.5 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥163.3 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥208.55 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥192.9 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥182.17 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥170.95 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 22.1% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 29.1% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 29.6% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.1% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.2% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | -7.6% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.4% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.1% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.4% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 28.8% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 94,741,793 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,653,362 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,579,550 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,437,900 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,325,700 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 27,802 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 26,880 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 24,890 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 24,286 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 24,118 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 88
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2023-04-01 → 2024-03-31 | ¥47m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2023-04-01 → 2024-03-31 | ¥23m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2024-03-31 | 116 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2024-03-31 | ¥604m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2024-03-31 | ¥604m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2024-03-31 | ¥216m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2024-03-31 | −¥542m |
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥360m |
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥304m |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥15.3bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥5.5bn |
| Children Businessreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥37m |
| Children Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥186m |
| Children Businessreportable segment | employees | at 2024-03-31 | 1458 pure |
| Children Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥10.2bn |
| Children Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥10.2bn |
| Children Businessreportable segment | segment assets | at 2024-03-31 | ¥10.1bn |
| Children Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥546m |
| Elderly Care Businessreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥7.1bn |
| Elderly Care Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥916m |
| Elderly Care Businessreportable segment | employees | at 2024-03-31 | 9619 pure |
| Elderly Care Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥53.9bn |
| Elderly Care Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥53.9bn |
| Elderly Care Businessreportable segment | segment assets | at 2024-03-31 | ¥40.4bn |
| Elderly Care Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥2.8bn |
| Medical Support Servicesreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥216m |
| Medical Support Servicesreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥84m |
| Medical Support Servicesreportable segment | employees | at 2024-03-31 | 22438 pure |
| Medical Support Servicesreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥70.5bn |
| Medical Support Servicesreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥70.5bn |
| Medical Support Servicesreportable segment | segment assets | at 2024-03-31 | ¥9.3bn |
| Medical Support Servicesreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥8.2bn |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥7.4bn |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥1.2bn |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥134.5bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥134.5bn |
| —segment total | segment assets | at 2024-03-31 | ¥59.7bn |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥11.5bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-04-01 → 2024-03-31 | ¥7.4bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-04-01 → 2024-03-31 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2024-03-31 | ¥135.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2024-03-31 | ¥135.1bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-03-31 | ¥59.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2024-03-31 | ¥11.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2022-04-01 → 2023-03-31 | ¥24m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2022-04-01 → 2023-03-31 | ¥20m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2023-03-31 | ¥591m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2023-03-31 | ¥591m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2023-03-31 | ¥216m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2023-03-31 | −¥607m |
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥201m |
| Reconciling Itemsreconciling | depreciation | 2022-04-01 → 2023-03-31 | ¥303m |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥12.6bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥5.1bn |
| Children Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥552m |
| Children Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥200m |
| Children Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥9.9bn |
| Children Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥9.9bn |
| Children Businessreportable segment | segment assets | at 2023-03-31 | ¥11.1bn |
| Children Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥504m |
| Elderly Care Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥1.3bn |
| Elderly Care Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥819m |
| Elderly Care Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥48.5bn |
| Elderly Care Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥48.5bn |
| Elderly Care Businessreportable segment | segment assets | at 2023-03-31 | ¥36.9bn |
| Elderly Care Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥2.5bn |
| Medical Support Servicesreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥178m |
| Medical Support Servicesreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥57m |
| Medical Support Servicesreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥72.0bn |
| Medical Support Servicesreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥72.0bn |
| Medical Support Servicesreportable segment | segment assets | at 2023-03-31 | ¥9.0bn |
| Medical Support Servicesreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥9.0bn |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥2.1bn |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥1.1bn |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥130.5bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥130.5bn |
| —segment total | segment assets | at 2023-03-31 | ¥57.0bn |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | ¥12.0bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥2.1bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥131.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥131.1bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥57.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥11.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2024-03-31 | 113 pure |
| Children Businessreportable segment | employees | at 2024-03-31 | 557 pure |
| Elderly Care Businessreportable segment | employees | at 2024-03-31 | 4441 pure |
| Medical Support Servicesreportable segment | employees | at 2024-03-31 | 22438 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,638
| Item | Context | Value | Unit |
|---|---|---|---|
| Percentage of shareholdings individuals and others | CurrentYearInstant_OrdinaryShareMember | 0.1631 | |
| Number of shares held | CurrentYearInstant_No1MajorShareholdersMember | 31805100 | |
| Shareholding ratio | CurrentYearInstant_No1MajorShareholdersMember | 0.3449 | |
| Number of shares held | CurrentYearInstant_No2MajorShareholdersMember | 8805600 | |
| Shareholding ratio | CurrentYearInstant_No2MajorShareholdersMember | 0.0955 | |
| Number of shares held | CurrentYearInstant_No3MajorShareholdersMember | 5482300 | |
| Shareholding ratio | CurrentYearInstant_No3MajorShareholdersMember | 0.0595 | |
| Number of shares held | CurrentYearInstant_No4MajorShareholdersMember | 4709500 | |
| Shareholding ratio | CurrentYearInstant_No4MajorShareholdersMember | 0.0511 | |
| Number of shares held | CurrentYearInstant_No5MajorShareholdersMember | 3412500 | |
| Shareholding ratio | CurrentYearInstant_No5MajorShareholdersMember | 0.0370 | |
| Number of shares held | CurrentYearInstant_No6MajorShareholdersMember | 2545200 | |
| Shareholding ratio | CurrentYearInstant_No6MajorShareholdersMember | 0.0276 | |
| Number of shares held | CurrentYearInstant_No7MajorShareholdersMember | 2150094 | |
| Shareholding ratio | CurrentYearInstant_No7MajorShareholdersMember | 0.0233 | |
| Number of shares held | CurrentYearInstant_No8MajorShareholdersMember | 2110012 | |
| Shareholding ratio | CurrentYearInstant_No8MajorShareholdersMember | 0.0229 | |
| Number of shares held | CurrentYearInstant_No9MajorShareholdersMember | 1516900 | |
| Shareholding ratio | CurrentYearInstant_No9MajorShareholdersMember | 0.0165 | |
| Number of shares held | CurrentYearInstant_No10MajorShareholdersMember | 1200600 | |
| Shareholding ratio | CurrentYearInstant_No10MajorShareholdersMember | 0.0130 | |
| Number of shares held | CurrentYearInstant | 63737806 | |
| Shareholding ratio | CurrentYearInstant | 0.6912 | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 2531100 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 92184100 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 921841 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | 26593 | |
| Number of shares issued shares voting rights | CurrentYearInstant | 94741793 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant | 921841 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant_Row1Member | 2531100 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant_Row1Member | 2531100 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant_Row1Member | 0.0267 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant | 2531100 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant | 2531100 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant | 0.0267 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row1Member | 940000000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row1Member | 10.0 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row2Member | 922000000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row2Member | 10.0 | |
| Number of male directors and other officers | FilingDateInstant | 7 | |
| Number of female directors and other officers | FilingDateInstant | 3 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.30 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E04878-000NodaToruMember | 23000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E04878-000KawanishiMasateruMember | 6000 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |